A Dowling
Overview
Explore the profile of A Dowling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
483
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dowling A, Lawrence K, Howe L, Scott I, Pomroy W
Vet Parasitol Reg Stud Reports
. 2025 Mar;
58:101201.
PMID: 40049992
The West Coast region of the South Island of New Zealand is recognised as having a high prevalence of liver fluke infection, however, few studies have tested this assumption. This...
2.
Dowling A, Lawrence K, Scott I, Howe L, Pomroy W
Vet Parasitol
. 2024 Sep;
332:110305.
PMID: 39293340
The liver fluke Fasciola hepatica is a trematode parasite of farmed livestock with worldwide distribution, causing chronic production losses and possible death from hepatobiliary damage. The effective management of liver...
3.
Dowling A, Lawrence K, Howe L, Scott I, Pomroy W
Vet Parasitol Reg Stud Reports
. 2024 Sep;
54:101102.
PMID: 39237240
In many regions of New Zealand liver fluke is endemic, infecting most grazing ruminants, including cattle, sheep, and deer. Restricting the economic losses and welfare costs associated with liver fluke...
4.
Gately L, Mesia C, Sepulveda J, Del Barco S, Pineda E, Girones R, et al.
J Neurooncol
. 2024 Apr;
168(2):299-306.
PMID: 38630385
Purpose: The impact of age on optimal management of glioblastoma remains unclear. A recent combined analysis of two randomised trials, GEINO14-01 and EX-TEM, found no benefit from extending post-radiation temozolomide...
5.
Gately L, Mesia C, Sepulveda J, Del Barco S, Pineda E, Girones R, et al.
J Neurooncol
. 2024 Jan;
166(3):417-418.
PMID: 38289531
No abstract available.
6.
Gately L, Mesia C, Sepulveda J, Del Barco S, Pineda E, Girones R, et al.
J Neurooncol
. 2023 Dec;
166(3):407-415.
PMID: 38153582
Purpose: The optimal duration of post-radiation temozolomide in newly diagnosed glioblastoma remains unclear, with no published phase III randomised trials. Standard-of-care stipulates 6 months. However, in routine care, it is...
7.
Gately L, McLachlan S, Dowling A, Philip J
J Clin Neurosci
. 2020 Nov;
81:284-289.
PMID: 33222931
Given the poor prognosis of glioblastoma, little focus has been placed on the needs of long-term survivors (those alive at least two years following diagnosis). The aim of this project...
8.
Gately L, McLachlan S, Philip J, Rathi V, Dowling A
J Clin Neurosci
. 2019 Aug;
68:1-8.
PMID: 31416731
Molecular aberrations of malignancy are becoming widely recognized as important predictive and prognostic markers for treatment response and survival in oncology and have been linked to the discovery of novel...
9.
Chia P, Chiang K, Snyder R, Dowling A
J Oncol Pharm Pract
. 2017 Dec;
24(4):264-271.
PMID: 29284360
Background Anthracycline-based chemotherapy is used in many malignancies. Current recommendations by several groups suggest cardiac monitoring prior to and during anthracycline therapy. We aim to review the usefulness of baseline...
10.
Gately L, McLachlan S, Dowling A, Philip J
J Cancer Surviv
. 2017 Feb;
11(4):447-452.
PMID: 28194640
Background: The median survival of glioblastoma is 12-14 months with less than 10% of patients surviving at least 2 years from diagnosis. Patients diagnosed with glioblastoma face poor prognosis, significant...